To tweet or not to tweet about schizophrenia systematic reviews (TweetSz): study protocol for a randomised controlled trial
Jayaram, Mahesh; Bodart, Angelique Y.M.; Sampson, Stephanie; Zhao, Sai; Montgomery, Alan A.; Adams, Clive E.
Angelique Y.M. Bodart
Alan A. Montgomery
Clive E. Adams
Introduction: The Cochrane Schizophrenia Group (CSzG) has produced and maintained systematic reviews of effects of interventions for schizophrenia and related illness. Each review has a Plain Language Summary (PLS), for those without specialised knowledge, and an abstract, which are freely available from The Cochrane Library (https://summaries.cochrane.org). Increasingly, evidence is being distributed using social media such as Twitter and Weibo (in China) alongside traditional publications.
Methods and analysis: In a prospective two-arm, parallel, open randomised controlled trial with a 1:1 allocation ratio, we will allocate 170 published systematic reviews into the intervention group (tweeting arm/Weibo arm) versus the control group (non-tweeting arm). Reviews will be stratified by baseline access activity, defined as high (≥19 views per week, n=14), medium (4.3 to 18.99 views per week, n=72) or low (
|Journal Article Type||Article|
|Publisher||BMJ Publishing Group|
|Peer Reviewed||Peer Reviewed|
|APA6 Citation||Jayaram, M., Bodart, A. Y., Sampson, S., Zhao, S., Montgomery, A. A., & Adams, C. E. (in press). To tweet or not to tweet about schizophrenia systematic reviews (TweetSz): study protocol for a randomised controlled trial. BMJ Open, 5, https://doi.org/10.1136/bmjopen-2015-007695|
|Copyright Statement||Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0|
To tweet or not to tweet about Schizophrenia systematic reviews BMJ OPen 20155e007695.pdf
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like